Stock Futures Up, Early Risers Edwards (EW), Tesla (TSLA)

 
Stock futures stitched tight gains Monday morning as commodities markets lulled and stocks in Europe pushed marginally higher. Early risers included Edwards Lifesciences (EW) and Tesla Motors (TSLA), Investor’s Business Daily reported.

The only economic release expected today is February factory orders from the Commerce Department. Services sector data for March are expected on Tuesday. The high point in a quiet week of economic news is likely to be minutes from the Federal Open Market Committee’s March 16 meeting, which are due out Wednesday and will be closely watched. Boston Federal Reserve Bank President Eric Rosengren speaks this morning.

Medical devices leader Edwards Lifesciences bolted 13% higher after announcing positive results on a clinical trial for its SAPIEN 3 aortic valve replacement.

Tesla Motors rose 4% after a tweet from Chief Executive Elon Musk announced orders for the new Tesla Model 3 rose to 276,000 by the end of the day Saturday.

EW is a Cabot Top Ten Trader stock and TSLA is a Cabot Stock of the Month.

Stock Picks

Loews Corp.

This undervalued stock has strong future earnings growth expectations.

Biogen

Biogen is the market-share leader in treating multiple sclerosis.

Weibo

One of Paul Godwin’s favorite stocks in his Cabot Emerging Markets Investor portfolio.

Cabot Wealth Advisory

Does Alibaba (BABA) Stock Measure Up to Amazon (AMZN)?

By Paul Goodwin on September 23, 2016

Alibaba (BABA) is the Amazon (AMZN) of China. But does BABA stock measure up to AMZN stock? Let’s break it down!Read More >

As Stock Market Trends Change, Invest in these New Leaders

By Michael Cintolo on September 22, 2016

History tells us that all stock market trends change, and if you don’t recognize the leaders of that change early, you risk missing out on the next big winners.Read More >

AMZN Stock vs. FB Stock: Which Is the Better Value Buy?

By J. Royden Ward on September 20, 2016

For the past five years, AMZN stock and FB stock have been two of the market's great growth stories. But could you make the case that either stock is still undervalued? Let’s break it down.Read More >